Safety of Propranolol for Infantile Hemangioma in Infants <5-Week Corrected Age

被引:0
|
作者
Barve, Ajit [1 ]
机构
[1] Dr Ajit Skin Clin, Dept Dermatol, Thana, Maharashtra, India
关键词
D O I
10.4103/ijpd.ijpd_53_22
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:188 / 190
页数:3
相关论文
共 50 条
  • [11] A Retrospective Study of Propranolol Therapy in 109 Infants with Infantile Hemangioma
    Gan, Li-qiang
    Ni, Si-li
    Tan, Qi
    Wang, Hua
    [J]. PEDIATRIC DERMATOLOGY, 2013, 30 (02) : 270 - 272
  • [12] Safety assessment of propranolol for infantile hemangioma: a study in an Asian population
    Yu, Lu
    Wei, Li
    Xu, Zigang
    Zhang, Bin
    Han, Xiaofeng
    Sun, Yujuan
    Liu, Yuanxiang
    Wang, Chen
    Qiu, Lei
    Xiu, Bingyu
    He, Rui
    Li, Li
    Ma, Lin
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (02) : 237 - 242
  • [13] Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review
    Leaute-Labreze, Christine
    Boccara, Olivia
    Degrugillier-Chopinet, Caroline
    Mazereeuw-Hautier, Juliette
    Prey, Sorilla
    Lebbe, Genevieve
    Gautier, Stephanie
    Ortis, Valerie
    Lafon, Martine
    Montagne, Agnes
    Delarue, Alain
    Voisard, Jean-Jacques
    [J]. PEDIATRICS, 2016, 138 (04)
  • [14] Sleep behavior of infants with infantile hemangioma treated with propranolol—a cohort study
    Martin Theiler
    Nicole Knöpfel
    Susanne von der Heydt
    Agnes Schwieger-Briel
    Isabelle Luchsinger
    Alexandra Smith
    Kristin Kernland-Lang
    Regula Waelchli
    Kathrin Neuhaus
    Malcolm Kohler
    Ralph Gnannt
    Sarah F. Schoch
    Lisa Weibel
    Salome Kurth
    [J]. European Journal of Pediatrics, 2021, 180 : 2655 - 2668
  • [15] Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants
    Hsu, Teng-Chin
    Wang, Jiaan-Der
    Chen, Chao-Huei
    Chang, Te-Kau
    Wang, Teh-Ming
    Chou, Chia-Man
    Lin, Heng-Kuei
    [J]. PEDIATRICS AND NEONATOLOGY, 2012, 53 (02): : 125 - 132
  • [16] Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study
    Nagata, Eiko
    Kashiwagura, Yasuharu
    Okada, Eisaku
    Tanaka, Shimako
    Sano, Shinichiro
    Nishida, Mitsuhiro
    Hayano, Satoshi
    Iwashima, Satoru
    Hakamata, Akio
    Odagiri, Keiichi
    Inui, Naoki
    Watanabe, Hiroshi
    Umemura, Kazuo
    Uchida, Shinya
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2022, 149 (02) : 60 - 65
  • [17] No Increased Risks Associated with Propranolol Treatment for Infantile Hemangioma in Preterm Infants were Identified at 3 Years of Age
    Li Li
    Li Wei
    Zi-Gang Xu
    Lin Ma
    [J]. American Journal of Clinical Dermatology, 2019, 20 : 289 - 293
  • [18] No Increased Risks Associated with Propranolol Treatment for Infantile Hemangioma in Preterm Infants were Identified at 3 Years of Age
    Li, Li
    Wei, Li
    Xu, Zi-Gang
    Ma, Lin
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 289 - 293
  • [19] Propranolol therapy in infantile hemangioma: correlation of age and duration of treatment to the outcomes
    Ali Farooq Al-Mayoof
    Ali Egab Joda
    Osama Esmaeel Almushhadany
    [J]. Annals of Pediatric Surgery, 15
  • [20] Propranolol therapy in infantile hemangioma: correlation of age and duration of treatment to the outcomes
    Al-Mayoof, Ali Farooq
    Joda, Ali Egab
    Almushhadany, Osama Esmaeel
    [J]. ANNALS OF PEDIATRIC SURGERY, 2019, 15 (1)